Repetitive transcranial magnetic stimulation: Does it have potential in the treatment of depression?

CNS Drugs

Volumn 17, Issue 6, 2003, Pages 383-403

  Padberg, Frank ^a   Möller, Hans Jürgen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CORTICOTROPIN; GLUTAMIC ACID; HYDROCORTISONE; HYDROGEN PEROXIDE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; THYROTROPIN; VASOPRESSIN;

BRAIN DEPTH STIMULATION; BRAIN FUNCTION; CLINICAL TRIAL; DISEASE COURSE; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; ELECTROCONVULSIVE THERAPY; ELECTRONEUROLOGY; EMOTION; FRONTAL CORTEX; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERMETHOD COMPARISON; LIMBIC CORTEX; MAJOR DEPRESSION; MENTAL DISEASE; MONOTHERAPY; MOOD; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; NORADRENERGIC SYSTEM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SAFETY; SEIZURE; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT FAILURE; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

ANIMALS; CLINICAL TRIALS; DEPRESSION; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION THERAPY; ELECTROCONVULSIVE THERAPY; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0038414536     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200317060-00002     Document Type: Review

References (143)

1. Berger M, Vollmann J, Hohagen F, et al. Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients. Am J Psychiatry 1997; 154: 870-2
2. George MS, Lisanby SH, Sackeim HA. Transcranial magnetic stimulation. Arch Gen Psychiatry 1999; 56: 300-11
3. Lisanby SH, Luber B, Perera T, et al. Transcranial magnetic stimulation: applications in basic neuroscience and neuropsychopharmacology. Int J Neuropsychopharmacol 2000; 3: 259-73
4. Wassermann EM, Lisanby SH. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol 2001; 112: 1367-77
5. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001; 25: 713-28
6. Barker AT, Jalinous R, Freeston IL. Noninvasive magnetic stimulation of human motor cortex. Lancet 1985; II: 1106-7
7. Faraday M. Effects on the production of electricity from magnetism. In: Faraday M, Williams LP, editors. New York: Basic Books, 1831: 531-40
8. Penfield W, Jasper H. Epilepsy and the functional anatomy of the human brain. Boston (MA): Little, Brown & Co, 1954
9. Hallett M. Transcranial magnetic stimulation: a tool for mapping the central nervous system. Electroencephalogr Clin Neurophysiol Suppl 1996; 46: 43-51
10. Hoffman RE, Cavus I. Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am J Psychiatry 2002; 159: 1093-102
11. Höflich G, Kasper S, Hufnagel A. et al. Application of transcranial magnetic stimulation in treatment of drug-resistant major depression. Hum Psychopharmacol 1993; 8: 361-5
12. Grisaru N, Yarovslavsky U, Abarbanel J, et al. Transcranial magnetic stimulation in depression and schizophrenia. Eur Neuropsychopharmacol 1994; 4: 287-8
13. George MS, Wassermann EM, Williams WA, et al. Daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995; 6: 1-6
14. Conca A, Koppi S, König P, et al. Transcranial magnetic stimulation: a novel antidepressive strategy? Neuropsychobiology 1996; 34: 204-7
15. Fleischmann A, Prolov K, Abarbanel J, et al. The effect of transcranial magnetic stimulation of rat brain on behavioral models of depression. Brain Res 1995; 699: 130-2
16. Zyss T, Gorka Z, Kowalska M, et al. Preliminary comparison of behavioral and biochemical effects of chronic transcranial magnetic stimulation and electroconvulsive shock in the rat. Biol Psychiatry 1997; 42: 920-4
17. Keck ME, Engelmann M, Müller MB, et al. Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. J Psychiatr Res 2000; 34: 265-76
18. Sachdev PS, McBride R, Loo CK, et al. Effects of different frequencies of transcranial magnetic stimulation (TMS) on the forced swim test model of depression in rats. Biol Psychiatry 2002; 51: 474-919
19. Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 1988; 94: 147-60
20. Belmaker RH, Grisaru N. Magnetic stimulation of the brain in animal depression models responsive to ECS. J ECT 1998; 14: 194-205
21. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation; 1996 Jun 5-7. Electroencephalogr Clin Neurophysiol 1998; 108: 1-16
22. Matsumiya Y, Yamamoto T, Yarita M, et al. Physical and physiological specification of magnetic pulse stimuli that produce cortical damage in rats. J Clin Neurophysiol 1992; 9: 278-87
23. Sgro JA, Ghatak NR, Stanton PC, et al. Repetitive high magnetic field stimulation: the effect upon rat brain. In: Levy WJ, Cracco RQ, Barker AT, et al., editors. Magnetic motor stimulation: basic principles and clinical experience (EEG Suppl 43). Amsterdam: Elsevier. 1991: 180-5
24. Counter SA. Neurobiological effects of extensive transcranial electromagnetic stimulation in an animal model. Electroencephalogr Clin Neurophysiol 1993; 89: 341-8
25. Post A, Müller MB, Engelmann M, et al. Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo. Eur J Neurosci 1999; 11: 3247-54
26. Fujiki M, Steward O. High frequency transcranial magnetic stimulation mimics the effects of ECS in upregulating astroglial gene expression in the murine CNS. Brain Res Mol Brain Res 1997; 44: 301-8
27. Steward O, Kelley MS, Torre ER. The process of reinnervation in the dentate gyms of adult rats: temporal relationship between changes in the levels of glial fibrillary acidic protein (GFAP) and GFAP mRNA in reactive astrocytes. Exp Neurol 1993; 124: 167-83
28. Muller MB, Toschi N, Kresse AE, et al. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology 2000; 23: 205-15
29. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539-47
30. Zetterstrom TS, Pei Q, Grahame-Smith DG. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res Mol Brain Res 1998; 57: 106-10
31. Zetterstrom TS, Pei Q, Madhav TR, et al. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 1999; 38: 1063-73
32. Czéh B, Welt T, Fischer AK, et al. Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. Biol Psychiatry 2002; 52: 1057-65
33. Juckel G, Mendlin A, Jacobs BL. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression. Neuropsychopharmacology 1999; 21: 391-8
34. Keck ME, Sillaber I, Ebner K, et al. Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. Eur J Neurosci 2000; 12: 3713-20
35. Kole MH, Fuchs E, Ziemann U, et al. Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats. Brain Res 1999; 826: 309-12
36. Ben-Shachar D, Gazawi H, Riboyad-Levin J, et al. Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain. Brain Res 1999; 816: 78-83
37. Gur E, Lerer B, Dremencov E, et al. Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. Neuroreport 2000; 11: 2925-9
38. Zis AP, Nomikos GG, Brown EE, et al. Neurochemical effects of electrically and chemically induced seizures: an in vivo microdialysis study in the rat hippocampus. Neuropsychopharmacology 1992; 7: 189-95
39. Gut E, Lerer B, Newman ME. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study. J Neural Transm 1997; 104: 795-804
40. Post A, Keck ME. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? J Psychiatr Res 2001; 35: 193-215
41. Keck ME, Welt T, Müller MB, et al. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology 2002; 43: 101-9
42. Ben-Shachar D, Belmaker RH, Grisaru N, et al. Transcranial magnetic stimulation induces alterations in brain monoamines. J Neural Transm 1997; 104: 191-7
43. McGarvey KA, Zis AP, Brown EE, et al. ECS-induced dopamine release: effects of electrode placement, anticonvulsant treatment, and stimulus intensity. Biol Psychiatry 1993; 34: 152-7
44. Yoshida K, Higuchi H, Kamata M, et al. Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22: 435-44
45. Thomas DN, Nutt DJ, Holman RB. Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex. Br J Pharmacol 1992; 106: 430-4
46. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996; 17: 187-205
47. Holsboer F. Stress, hypercortism and corticosteroid receptors in depression: implications for therapy. J Affect Disord 2001; 62: 77-91
48. Reul JM, Stec I, Soder M, et al. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 1993; 133: 312-20
49. Reul JM, Labeur MS, Grigoriadis DE, et al. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 1994; 60: 509-19
50. Keck ME, Welt T, Post A, et al. Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology 2001; 24: 337-49
51. George MS, Wassermann EM, Williams WA, et al. Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci 1996; 8: 172-80
52. Pascual-Leone A, Catalá MD, Pascual-Leone Pascual A. Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood. Neurology 1996; 46: 499-502
53. Dearing MJ. Mood effects of prefrontal repetitive high-frequency TMS in healthy volunteers. CNS Spectrums 1997; 2: 53-68
54. George MS, Speer AM, Wassermann EM, et al. Repetitive TMS as a probe of mood in health and disease. CNS Spectrums 1997; 2: 39-44
55. Cohrs S, Tergau F, Riech S, et al. High-frequency repetitive transcranial magnetic stimulation delays rapid eye movement sleep. Neuroreport 1998; 9: 3439-43
56. Nedjat S, Folkerts HW. Induction of a reversible state of hypomania by rapid-rate transcranial magnetic stimulation over the left prefrontal cortex. J ECT 1999; 15: 166-8
57. Mosimann UP, Ribs TA, Engeler J, et al. Mood effects of repetitive transcranial magnetic stimulation of left prefrontal cortex in healthy volunteers. Psychiatry Res 2000; 94: 251-6
58. Padberg F, Juckel G, Prass A, et al. Prefrontal cortex modulation of mood and emotionally induced facial expressions: a transcranial magnetic stimulation study. J Neuropsychiatry Clin Neurosci 2001; 13: 206-12
59. Grisaru N, Bruno R, Pridmore S. Effect on the emotions of healthy individuals of slow repetitive transcranial magnetic stimulation applied to the prefrontal cortex. J ECT 2001; 17: 184-9
60. Jenkins J, Shajahan PM, Lappin JM, et al. Right and left prefrontal transcranial magnetic stimulation at 1 Hz does not affect mood in healthy volunteers. BMC Psychiatry 2002; 2: 1
61. Schutter D, van Honk J, d'Alfonso A, et al. Effects of slow rTMS at the right dorsolateral prefrontal cortex on EEG asymmetry and mood. Neuroreport 2001; 12: 445-7
62. Cohrs S, Tergau F, Korn J, et al. Suprathreshold repetitive transcranial magnetic stimulation elevates thyroid-stimulating hormone in healthy male subjects. J Nerv Ment Dis 2001; 189: 393-7
63. Paus T, Jech R, Thompson CJ, et al. Transcranial magnetic stimulation during positron emission tomography: a new method for studying connectivity of the human cerebral cortex. J Neurosci 1997; 17: 3178-84
64. Fox P, Ingham R, George MS, et al. Imaging human intracerebral connectivity by PET during TMS. Neuroreport 1997; 8: 2787-91
65. Teneback CC, Nahas Z, Speer AM, et al. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci 1999; 11: 426-35
66. Paus T, Castro-Alamancos MA, Petrides M. Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci 2001; 14: 1405-11
67. Shajahan PM, Glabus MF, Steele JD, et al. Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 945-54
68. Kimbrell TA, Dunn RT, George MS, et al. Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers. Psychiatry Res 2002; 115: 101-13
69. Baxter LRJ, Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46: 243-50
70. Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 2000; 126: 413-31
71. Strafella AP, Paus T, Barrett J, et al. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001; 21: RC157
72. Post RM, Gerner RH, Carman JS, et al. Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response. Arch Gen Psychiatry 1978; 35: 609-15
73. Kapur S, Mann JJ. Role of the dopaminergic system in depression. Biol Psychiatry 1992; 32: 1-17
74. Brown AS, Gershon S. Dopamine and depression. J Neural Transm Gen Sect 1993; 91: 75-109
75. Rampello L, Nicoletti G, Raffaele R. Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatr Scand 1991; 84: 552-4
76. Bonnet JJ, Chagraoui A, Protais P, et al. Interactions of amineptine with the neuronal dopamine uptake system: neurochemical in vitro and in vivo studies. J Neural Transm 1987; 69: 211-20
77. Golden RN, Rudorfer MV, Sherer MA, et al. Bupropion in depression. I: biochemical effects and clinical response. Arch Gen Psychiatry 1988; 45: 139-43
78. Grunhaus L, Dannon PN, Schreiber S, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry 2000; 47: 314-24
79. Zwanzger P, Ella R, Keck ME, et al. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry 2002; 51: 602-3
80. Kolbinger HM, Hop̈flich G, Hufnagel A, et al. Transcranial magnetic stimulation (TMS) in the treatment of major depression: a pilot study. Hum Psychopharmacol 1995; 10: 305-10
81. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 2002; 5: 73-103
82. Figiel G, Epstein C, McDonald W, et al. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. J Neuropsychiatry Clin Neurosci 1998; 10: 20-5
83. Triggs WJ, McCoy KJM, Greer R, et al. Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold. Biol Psychiatry 1999; 45: 1440-6
84. Padberg F, Schüle C, Zwanzger P, et al. Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depression. J Psychiatr Res 2002; 36: 131-5
85. Pridmore S, Rybak M, Turnier-Shea Y, et al. A naturalistic study of response in melancholia to transcranial magnetic stimulation (TMS). German J Psychiatry 1999; 2: 13-21
86. Nemeroff CB, Evans DL. Thyrotropin releasing hormone (TRgH), the thyroid axis and affective disorders. Ann N Y Acad Sci 1989; 533: 304-10
87. Pridmore S. Rapid transcranial magnetic stimulation (rTMS) and normalisation of the dexamethasone suppression test (DST). Psychiatry Clin Neurosci 1999; 53: 33-7
88. Reid PD, Pridmore S. Dexamethasone suppression test reversal in rapid transcranial magnetic stimulation-treated depression. Aust N Z J Psychiatry 1999; 33: 274-7
89. Zwanzger P, Baghai TC, Padberg F, et al. The combined dexamethasone-corticotropin-releasing-hormone test (DEX/CRH test) before and after treatment with repetitive transcranial magnetic stimulation in major depression. Psychoneuroendocrinology 2003; 28: 376-85
90. Szuba M, O'Reardon JP, Rai AS, et al. Acute mood and TSH effects of transcranial magnetic stimulation in major depression. Biol Psychiatry 2001; 50: 22-7
91. Rupprecht R, di Michele F, Hermann B, et al. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Brain Res Rev 2001; 37: 59-67
92. Romeo E, Strohle A, Spalletta G, et al. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 1998; 155: 910-3
93. Uzunova V, Sheline Y, Davis JM, et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 1998; 95: 3239-44
94. Padberg F, di Michele F, Zwanzger P, et al. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Neuropsychopharmacology 2002; 27: 874-8
95. Kimbrell TA, Little JT, Dunn RT, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 1999; 46: 1603-13
96. Eschweiler GW, Wegerer C, Schlotter W, et al. Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Res 2000; 99: 161-72
97. Mottaghy F, Keller C, Gangitano M, et al. Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res 2002; 115: 1-14
98. Speer AM, Kimbrell TA, Wassermann EM, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry 2000; 48: 1133-41
99. Catafau AM, Perez V, Gironell A. et al. SPECT mapping of cerebral activity changes induced by repetitive transcranial magnetic stimulation in depressed patients: a pilot study. Psychiatry Res 2001; 106: 151-60
100. Conca A, Peschina W, Konig P, et al. Effect of chronic repetitive transcranial magnetic stimulation on regional cerebral blood flow and regional cerebral glucose uptake in drug treatment-resistant depressives: a brief report. Neuropsychobiology 2002; 45: 27-31
101. Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002; 159: 728-37
102. Thase ME. How should efficacy be evaluated in randomized clinical trials of treatments for depression? J Clin Psychiatry 1999; 60 Suppl. 4: 23-31
103. Moller HJ. Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale. Eur Arch Psychiatry Clin Neurosci 2001; 251 Suppl. 2: II13-20
104. Khan A, Khan S, Brown WA. Are placebo controls necessary to test new antidepressants and anxiolytics? Int J Neuropsychopharmacol 2002; 5: 193-7
105. Pascual-Leone A, Rubio B, Pallardó F, et al. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996; 348: 233-7
106. George MS, Wassermann EM, Kimbrell TA, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry 1997; 154: 1752-6
107. Padberg F, Zwanzger P, Thoma H, et al. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res 1999; 88: 163-71
108. Klein E, Kreinin I, Chistyakov A, et al. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression. Arch Gen Psychiatry 1999; 56: 315-20
109. Garcia-Toro M, Mayol A, Arnillas H, et al. Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression. J Affect Disord 2001; 64: 271-5
110. Berman RM, Narasimhan M, Sanacora G. et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry 2000; 47: 332-7
111. George MS, Nahas Z, Molloy M, et al. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 2000; 48: 962-70
112. Padberg F, Zwanzger P, Keck ME, et al. Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity. Neuropsychopharmacology 2002; 27: 638-45
113. Loo C, Mitchell P, Sachdev P, et al. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry 1999; 156: 946-8
114. Manes F, Jorge R, Morcuende M, et al. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int Psychogeriatr 2001; 13: 225-31
115. Loo CK, Taylor JL, Gandevia SC, et al. Transcranial magnetic stimulation (TMS) in controlled treatment studies: are some "sham" forms active? Biol Psychiatry 2000; 47: 325-31
116. Lisanby SH, Gutman D, Luber B, et al. Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biol Psychiatry 2001; 49: 460-3
117. Post RM, Kimbrell TA, McCann UD, et al. Repetitive transcranial magnetic stimulation as a neuropsychiatric tool: present status and future potential. J ECT 1999; 15: 39-59
118. Nahas Z, Lomarev M, Roberts DR, et al. Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. Biol Psychiatry 2001; 50: 712-20
119. Kozel FA, Nahas Z, deBrux C, et al. How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation. J Neuropsychiatry Clin Neurosci 2000; 12: 376-84
120. Mosimann U, Marré SC, Werlen S, et al. Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance. Arch Gen Psychiatry 2002; 59: 560-1
121. Martin JL, Barbanoj MJ, Schlaepfer TE, et al. Transcranial magnetic stimulation for treating depression. Available in the Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2002: CD003493
122. Pridmore S, Bruno R, Turnier-Shea Y, et al. Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. Int J Neuropsychopharmacol 2000; 3: 129-34
123. Janicak PG, Dowd SM, Martis B, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry 2002; 51: 659-67
124. Grunhaus L, Schreiber S, Dolberg OT, et al. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry 2003; 53: 324-31
125. Nahas Z, DeBrux C, Chandler V, et al. Lack of significant changes on magnetic resonance scans before and after 2 weeks of daily left prefrontal repetitive transcranial magnetic stimulation for depression. J ECT 2000; 16: 380-90
126. Loo CK, Sachdev PS, Elsayed H, et al. Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychological functioning, electroencephalogram and auditory threshold in depressed patients. Biol Psychiatry 2001; 49: 615-23
127. Speer AM, Repella JD, Figueras S, et al. Lack of adverse cognitive effects on 1 Hz and 20 Hz repetitive transcranial magnetic stimulation at 100% of motor threshold over left prefrontal cortex in depression. J ECT 2001; 17: 259-63
128. Conca A, Konig P, Hausmann A. Transcranial magnetic stimulation induces 'pseudoabsence seizure'. Acta Psychiatr Scand 2000; 101: 246-8
129. Dolberg OT, Schreiber S, Grunhaus L. Transcranial magnetic stimulation-induced switch into mania: a report of two cases. Biol Psychiatry 2001; 49: 468-70
130. Ella R, Zwanzger P, Stampfer R, et al. Switch to mania after slow rTMS of the right prefrontal cortex [letter]. J Clin Psychiatry 2002; 63: 249
131. Lisanby SH, Luber B, Sackeim HA, et al. Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Arch Gen Psychiatry 2001; 58: 199-200
132. Lisanby SH, Schlaepfer TE, Fisch HU, et al. Magnetic seizure therapy of major depression. Arch Gen Psychiatry 2001; 58: 303-5
133. Schiffer F, Stinchfield Z, Pascual-Leone A. Prediction of clinical response to transcranial magnetic stimulation for depression by baseline lateral visual-field stimulation. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15: 18-27
134. Eschweiler GW, Plewnia C, Bartels M. Which patients with major depression benefit from prefrontal repetitive magnetic stimulation? [in German]. Fortschr Neurol Psychiatr 2001; 69: 402-9
135. Post RM, Kimbrell T, Frye M, et al. Implications of kindling and quenching for the possible frequency dependence of rTMS. CNS Spectrums 1997; 2: 54-60
136. McConnell KA, Nahas Z, Shastri A, et al. The transcranial magnetic stimulation motor threshold depends on the distance from coil to underlying cortex: a replication in healthy adults comparing two methods of assessing the distance to cortex. Biol Psychiatry 2001; 49: 454-9
137. Parker G, Hadzi-Pavlovic D, Brodaty H, et al. Sub-typing depression. II: clinical distinction of psychotic depression and non-psychotic melancholia. Psychol Med 1995; 25: 825-32
138. Dannon PN, Grunhaus L. Effect of electroconvulsive therapy in repetitive transcranial magnetic stimulation non-responder MDD patients: a preliminary study. Int J Neuropsychopharmacol 2001; 4: 265-8
139. Wu J, Buchsbaum MS, Gillin JC, et al. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 1999; 156: 1149-58
140. Herwig U, Padberg F, Unger J, et al. Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry 2001; 50: 58-61
141. Garcia-Toro M, Pascual-Leone A, Romera M, et al. Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression. J Neurol Neurosurg Psychiatry 2001; 71: 546-8
142. Eichhammer P, Kharraz A, Wiegand R, et al. Sleep deprivation in depression stabilizing antidepressant effects by repetitive transcranial magnetic stimulation. Life Sci 2002; 70: 1741-9
143. Pridmore S. Substitution of rapid transcranial magnetic stimulation treatments for electroconvulsive therapy treatments in a course of electroconvulsive therapy. Depress Anxiety 2000; 12: 118-23